Merck Sharpe & Dohme sues Lupin over Januvia patent

Healthcare 2020-09-07 2:44 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

US pharmaceutical giant Merck Sharp & Dohme has taken a unit of Indian generic manufacturer Lupin to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

Merck Sharp & Dohme slams Wyeth vaccine patent claims as ‘hearsay and speculation’

Allens 2019-02-06 2:44 pm By Miklos Bolza

Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine

Allens 2018-12-03 2:44 pm By Miklos Bolza

Merck Sharp & Dohme loses key battle in trade mark case ahead of trial

Angela McDonald 2019-07-15 2:44 pm By Miklos Bolza

Wyeth loses privilege claim over Allens docs in Merck’s vaccine patent case

Allens 2019-10-01 2:44 pm By Miklos Bolza

Merck Sharpe & Dohme sues Lupin over Januvia patent

Healthcare 2020-09-07 2:44 pm By Cat Fredenburgh

For information on rights and reprints, contact subscriptions@lawyerly.com.au